Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Mater Sci Eng C Mater Biol Appl. 2016 Apr 28;67:59–64. doi: 10.1016/j.msec.2016.04.093

Fig. 4.

Fig. 4

Shows the cell viability assay analysis using C-IO MNPs. Part a) Dose dependent exposure of uncoated iron oxide and curcumin-iron oxide nanoparticles towards HUVECs for 24 hours followed by viability analysis using Calcein AM red-orange live cell tracer. Inset: Fluorescent images of the HUVECs after 24-hour exposure followed by calcein AM red-orange dying. Part b) Protection against PCB 126 induced inflammation. HUVECs preincubated with 10 µg/mL curcumin iron oxide nanoparticles for 0, 12 and 24 hours followed by 24-hour exposure to 50 µM PCB126.